Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Tonix Pharmaceuticals Hldg C (TNXP)

79 + Investors. Track Smart Money conviction in TNXP. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +9
Streak
6Q ▲
Buyers last Q
66%

Smart Money Signals — TNXP

Based on 80 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q
For 6 consecutive quarters, more hedge funds added TNXP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
80 hedge funds hold TNXP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +233% more funds vs a year ago

fund count last 6Q
+56 new funds entered over the past year (+233% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 66% buying

52 buying27 selling
Last quarter: 52 funds were net buyers (18 opened a brand new position + 34 added to an existing one). Only 27 were sellers (18 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~18 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 27 → 18 → 20 → 18. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 55% entered in last year

■ 2% conviction (2yr+) ■ 42% medium ■ 55% new
Only 2 funds (2%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💎

Buying through price weakness — shares +32%, value +16%

Value
+16%
Shares
+32%
Last quarter: funds added +32% more shares while total portfolio value only changed +16%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

23 → 27 → 18 → 20 → 18 new funds/Q
New funds entering each quarter: 27 → 18 → 20 → 18. TNXP is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🌱

Early stage — 96% of holders entered in last year

■ 2% veterans ■ 1% 1-2yr ■ 96% new
Of 85 current holders: 82 (96%) entered in the past year, only 2 (2%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
🏆

Elite ownership — 42% AUM from top-100 funds

42% from top-100 AUM funds
28 of 79 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in TNXP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
5.9
out of 10
Moderate Exit Risk
Exit risk score 5.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TNXP

In 2026 Q1, 52 hedge funds were net buyers of TNXP (18 opened a new position, 34 added to an existing one), while 27 reduced or exited (18 trimmed, 9 sold completely) — a 66% buyer ratio, indicating clear institutional accumulation. This marks 6 consecutive quarters of net institutional buying — a persistent conviction signal. 42% of total institutional value in TNXP is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +9 funds (more new holders than closures). Total institutional holders: 80.

Hedge Fund Ownership: TNXP

How many hedge funds hold TNXP — quarterly history vs. share price
Quarterly hedge fund ownership of TNXP vs. share price

Market Analysis: TNXP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TNXP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Tonix Pharmaceuticals Hldg C (TNXP) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TNXP has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
TNXP
nan%
XLV
+2.1%

TNXP outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
TNXP
nan%
XLV
+3.2%

Since the filing became public, TNXP outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

14 top-rated funds 0 high-conviction
Consensus
5.1
/ 10
breadth
×
Elite
0.5
/ 10
conviction
Hedge Fund Positioning: TNXP
79 + Investors

Track Smart Money conviction in TNXP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 79 71 11.27%
13F Shares 5M 4M 32.3%
Total Value $70M $60M 16.43%
New Positions 17 20 -3
Increased Positions 34 35 -1
Closed Positions 9 7 +2
Reduced Positions 15 8 +7
Total Calls 3 2 50.0%
Total Puts 3 3 -
PUT/CALL Ratio 1.0 1.5 Neutral

Statistics: TNXP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

79 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TNXP. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TNXP holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Jones Hill Capital LP 1.33% 452,116 $6.2M
2 Superstring Capital Management LP 0.62% 63,540 $874K
3 SJS Investment Consulting Inc. 0.02% 10,004 $138K
4 Cornerstone National Bank & Trust Co 0.02% 3,330 $46K
5 Balyasny Asset Management L.P. 0.01% 313,082 $4.3M
6 Leonteq Securities AG 0.00% 5,700 $78K
7 Quadrature Capital Ltd 0.00% 17,410 $239K
8 Essential Partners LLC 0.00% 506 $7K
9 Gen-Wealth Partners Inc 0.00% 533 $7K
10 Point72 Asset Management, L.P. 0.00% 125,414 $1.7M
11 State of Wyoming 0.00% 1,176 $16K
12 Millennium Management LLC 0.00% 219,673 $3.0M
13 Citadel Advisors LLC 0.00% 468,712 $6.4M
14 Aqr Capital Management LLC 0.00% 161,208 $2.2M
15 Ieq Capital, LLC 0.00% 14,358 $197K
16 Dogwood Wealth Management LLC 0.00% 110 $2K
17 Caitlin John, LLC 0.00% 77 $1K
18 Wealth Preservation Advisors, LLC 0.00% 55 —
19 MetLife Investment Management, LLC 0.00% 8,590 $118K
20 Police & Firemen's Retirement System of New Jersey 0.00% 4,911 $68K
21 UBS Group AG 0.00% 231,678 $3.2M
22 Tower Research Capital LLC (TRC) 0.00% 1,178 $16K
23 IFP Advisors, Inc 0.00% 1,356 $19K
24 Ameritas Investment Partners, Inc. 0.00% 773 $11K
25 Vanguard Fiduciary Trust Co 0.00% 84,270 $1.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Tonix Pharmaceuticals Hldg C (TNXP)

What does the Smart Money Trend signal show for TNXP?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added TNXP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TNXP?

More buyers than sellers — 66% buying: Last quarter: 52 funds were net buyers (18 opened a brand new position + 34 added to an existing one). Only 27 were sellers (18 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for TNXP holders?

Elite ownership — 42% AUM from top-100 funds: 28 of 79 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in TNXP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held TNXP?

Mostly new holders — 55% entered in last year: Only 2 funds (2%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Tonix Pharmaceuticals Hldg C (TNXP) following the 2026 Q1 hedge fund 13F filings?

As of today, TNXP has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), TNXP has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →